Longer-term aspirin use and subsequent ovarian cancer risk in the Ovarian Cancer Cohort Consortium.
Long-term use of aspirin, and particularly low-dose aspirin, is associated with lower ovarian cancer risk, especially among individuals with other established risk factors for ovarian cancer. Research should continue to explore the potential role of long-term, low-dose aspirin use for ovarian cancer primary prevention.
Authors
- Melissa A. Merritt (ORCID: https://orcid.org/0000-0002-5067-6119)
- L. Liao
- N. Hakansson
- Wenyi Fan (ORCID: https://orcid.org/0000-0002-7875-7404)
- Mary K. Townsend (ORCID: https://orcid.org/0000-0003-2452-4477)
- H.R. Harris
- Lauren M. Hurwitz (ORCID: https://orcid.org/0000-0001-8932-5028)
- Trabert Britton
- Alicja Wolk
- Kim Robien
- Jenny N. Poynter
- Shelley S Tworoger
- A. V. Patel
- Brett M Reid
- Wei Zheng
- James V Lacey
- Dale P Sandler
- Clara Bodelon
- Andrew T Chan
- Katie M O'Brien
Institutions
- American Cancer Society (US)
- Milken Institute (US)
- Children's Mercy Hospital (US)
- Oregon Health & Science University (US)
- German Cancer Research Center (DE)
- University of Utah (US)
- Heidelberg University (DE)
- Huntsman Cancer Institute (US)
- Karolinska Institutet (SE)
- Moffitt Cancer Center (US)
- Massachusetts General Hospital (US)
- Fred Hutch Cancer Center (US)
- National Institute of Environmental Health Sciences (US)
- City of Hope (US)
- Cancer Registry of Norway (NO)
- University of Minnesota Medical Center (US)
- National Cancer Institute (US)
- University of Missouri–Kansas City (US)
- Vanderbilt University Medical Center (US)
- Cancer Council NSW (AU)
Publication Details
- Journal
- PubMed
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1093/ije/dyag019
- Primary Topic
- Inflammatory mediators and NSAID effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00